Abstract: The microwave sterilization chamber (10) is made in the shape of a downwardly open bell which can be sealed by a base structure (6, 19, 20) which carries means (5) for gripping and rotating the canister (1) filled with waste, which can be moved by suitable means from a low position for the filling and discharge of the canister (1) to a raised position for the closure of said chamber and for the insertion of the full canister (1) into the chamber, each canister being provided with means by which it can be removably supported by said means of gripping and rotating the sterilization chamber (10), and can be gripped by the manipulating means (SM) which transfer said canister between the different operating stations of the machine.

Abstract: The microwave sterilization chamber (10) is made in the shape of a downwardly open bell which can be sealed by a base structure (6, 19, 20) which carries means (5) for gripping and rotating the canister (1) filled with waste, which can be moved by suitable means from a low position for the filling and discharge of the canister (1) to a raised position for the closure of said chamber and for the insertion of the full canister (1) into the chamber, each canister being provided with means by which it can be removably supported by said means of gripping and rotating the sterilization chamber (10), and can be gripped by the manipulating means (SM) which transfer said canister between the different operating stations of the machine.

Abstract: A plasma generator comprising a propagation chamber propagating an electromagnetic radiation, and a plasma-generating chamber associated with the propagation chamber; said propagation chamber has a passage region of increasing width on moving away from the entrance region for insertion of the electromagnetic radiation into the propagation chamber. The passage region enables an at least partial passage of the electromagnetic radiation towards the plasma-generating chamber.

Abstract: A plasma generator comprising a propagation chamber propagating an electromagnetic radiation, and a plasma-generating chamber associated with the propagation chamber; said propagation chamber has a passage region of increasing width on moving away from the entrance region for insertion of the electromagnetic radiation into the propagation chamber. The passage region enables an at least partial passage of the electromagnetic radiation towards the plasma-generating chamber.

Abstract: The invention provides a pharmaceutical formulation comprising: (1) THAM, which is tris(hydroxymethyl)aminomethane, as a selective absorbefacient to enhance through the nasal mucosa-lined epithelium the absorption of substances of peptide nature; and (2) a therapeutically effective amount of active nasal peptide, its pharmaceutically acceptable salt or its peptidic fragment; in a pharmaceutically acceptable, aqueous liquid diluent or carrier, said formulation being in a form suitable for nasal administration.

Abstract: Pharmaceutically/storage-stable, water-resistant formulations of nicorandil comprise unit dosage coronary vasodilating amounts thereof in association, e.g., in suspension or in dispersion, with a pharmaceutically acceptable, characteristically low density dimethyl polysiloxane chemically compatible therewith, e.g., dimethicone or simethicone, are well suited for encapsulation within hard or soft gelatin capsules for oral/sublingual administration.

Abstract: The water soluble acid addition salts of an NSAID, such as acetylsalicylic acid, fenbufen, diflunisal, piroxicam, naproxen, or the like, with either glucamine or meglumine (N-methylglucamine) are useful anti-inflammatory and analgesic drugs, well adopted for parenteral, oral, rectal or topical administration.